Illumina Signs Master Supply Agreement to Provide Next-Generation ... Businessweek “The HLA typing assays we are developing on Illumina's family of NGS platforms will provide physicians with the ability to more accurately match bone marrow donors to recipients.” “We are excited to support LabCorp's ability to offer more NGS-based ... |
